Abstract:A few decades ago, drug discovery and development were limited to a bunch of medicinal chemists working in a lab with enormous amount of testing, validations, and synthetic procedures, all contributing to considerable investments in time and wealth to get one drug out into the clinics. The advancements in computational techniques combined with a boom in multi-omics data led to the development of various bioinformatics/pharmacoinformatics/cheminformatics tools that have helped speed up the drug development process. But with the advent of artificial intelligence (AI), machine learning (ML) and deep learning (DL), the conventional drug discovery process has been further rationalized. Extensive biological data in the form of big data present in various databases across the globe acts as the raw materials for the ML/DL-based approaches and helps in accurate identifications of patterns and models which can be used to identify therapeutically active molecules with much fewer investments on time, workforce and wealth. In this review, we have begun by introducing the general concepts in the drug discovery pipeline, followed by an outline of the fields in the drug discovery process where ML/DL can be utilized. We have also introduced ML and DL along with their applications, various learning methods, and training models used to develop the ML/DL-based algorithms. Furthermore, we have summarized various DL-based tools existing in the public domain with their application in the drug discovery paradigm which includes DL tools for identification of drug targets and drug–target interaction such as DeepCPI, DeepDTA, WideDTA, PADME DeepAffinity, and DeepPocket. Additionally, we have discussed various DL-based models used in protein structure prediction, de novo design of new chemical scaffolds, virtual screening of chemical libraries for hit identification, absorption, distribution, metabolism, excretion, and toxicity (ADMET) prediction, metabolite prediction, clinical trial design, and oral bioavailability prediction. In the end, we have tried to shed light on some of the successful ML/DL-based models used in the drug discovery and development pipeline while also discussing the current challenges and prospects of the application of DL tools in drug discovery and development. We believe that this review will be useful for medicinal and computational chemists searching for DL tools for use in their drug discovery projects.

Morphological Profiling for Drug Discovery in the Era of Deep Learning

Generalizable Morphological Profiling of Cells by Interpretable Unsupervised Learning

Rapid and Accurate Identification of Cell Phenotypes of Different Drug Mechanisms by Using Single-Cell Fluorescence Images Via Deep Learning

Deep Learning-Based HCS Image Analysis for the Enterprise

Deep Mining of Subtle Differences in Cell Morphology Via Deep Learning

DeepLearnMOR: a Deep-Learning Framework for Fluorescence Image-Based Classification of Organelle Morphology.

Predicting cell morphological responses to perturbations using generative modeling

A compact review of progress and prospects of deep learning in drug discovery

Information‐Distilled Generative Label‐Free Morphological Profiling Encodes Cellular Heterogeneity

Deep learning tools for advancing drug discovery and development

Information-Distilled Generative Label-Free Morphological Profiling Encodes Cellular Heterogeneity

Deep learning large-scale drug discovery and repurposing

Applications of Deep-Learning in Exploiting Large-Scale and Heterogeneous Compound Data in Industrial Pharmaceutical Research

De Novo Generation and Identification of Novel Compounds with Drug Efficacy Based on Machine Learning

The rise of deep learning in drug discovery

Machine-learning-guided quantitative delineation of cell morphological features and responses to nanomaterials

Confounder-aware foundation modeling for accurate phenotype profiling in cell imaging

Deep Learning in Drug Discovery: Current Landscape and Future Prospects

Cell morphological representations of genes enhance prediction of drug targets

From Pixels to Phenotypes: Integrating Image-Based Profiling with Cell Health Data Improves Interpretability

On Modeling and Utilizing Chemical Compound Information with Deep Learning Technologies: A Task-oriented Approach